logo
AI Icon𝛼SK or Search
ENTITY
Alexion Pharmaceuticals

Alexion Pharmaceuticals (ALXN US)

39
Analysis
Health Care • United States
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
more
Exchange Announcement • 16 Nov 2022 16:20

US SEC Form SC TO-T/A for Alexion Pharmaceuticals Inc

Exchange Announcement • 19 Oct 2022 00:02

US SEC Form SC TO-T for Alexion Pharmaceuticals Inc

Exchange Announcement • 04 Oct 2022 00:45

US SEC Form SC TO-C for Alexion Pharmaceuticals Inc

Exchange Announcement • 02 Aug 2021 17:02

US SEC Form 15-12G for Alexion Pharmaceuticals Inc

Exchange Announcement • 24 Jul 2021 00:54

Statement of changes in beneficial ownership of securities (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x